178 related articles for article (PubMed ID: 23399737)
21. Infliximab- and azathioprine-related severe neutropenia and thrombocytopenia in a case with Crohn's disease.
Köksal AR; Alkim C; Altinkaya E; Buğdaci MS; Özdoğan O; Boğa S; Alkim H; Sökmen M
Turk J Gastroenterol; 2011 Oct; 22(5):537-9. PubMed ID: 22234764
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate.
Shukla T; Jin J; Marginean EC; Saloojee N
Can J Gastroenterol Hepatol; 2014 Jan; 28(1):11-2. PubMed ID: 24416734
[No Abstract] [Full Text] [Related]
23. Epstein-Barr virus-associated lymphoma in Crohn's disease.
Losco A; Gianelli U; Cassani B; Baldini L; Conte D; Basilisco G
Inflamm Bowel Dis; 2004 Jul; 10(4):425-9. PubMed ID: 15475752
[TBL] [Abstract][Full Text] [Related]
24. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.
Velayos FS; Sandborn WJ
Inflamm Bowel Dis; 2004 Sep; 10(5):657-60. PubMed ID: 15472531
[TBL] [Abstract][Full Text] [Related]
25. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
26. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
[No Abstract] [Full Text] [Related]
27. Evaluation of "top-down" treatment of early Crohn's disease by double balloon enteroscopy.
Fan R; Zhong J; Wang ZT; Li SY; Zhou J; Tang YH
World J Gastroenterol; 2014 Oct; 20(39):14479-87. PubMed ID: 25339835
[TBL] [Abstract][Full Text] [Related]
28. Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.
Chen SC; Cummings OW; Hartley MP; Filomena CA; Cho WK
Dig Dis Sci; 2006 May; 51(5):952-5. PubMed ID: 16670938
[TBL] [Abstract][Full Text] [Related]
29. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Crohn's disease by infliximab. About 20 cases].
Serghini M; Karoui S; Meknini M; Matri S; Kallel L; Fekih M; Boubaker J; Filali A
Tunis Med; 2009 Sep; 87(9):579-82. PubMed ID: 20180377
[TBL] [Abstract][Full Text] [Related]
31. EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?
Allen PB; Laing G; Connolly A; O'Neill C
BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24081592
[TBL] [Abstract][Full Text] [Related]
32. [Maintenance treatment by anti-tumor necrosis factor monoclonal antibody in Crohn's disease--long-term effects and safety].
Matsui T
Nihon Shokakibyo Gakkai Zasshi; 2008 May; 105(5):649-58. PubMed ID: 18460853
[No Abstract] [Full Text] [Related]
33. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
Haveran LA; Sehgal R; Poritz LS; McKenna KJ; Stewart DB; Koltun WA
Dis Colon Rectum; 2011 Jan; 54(1):15-20. PubMed ID: 21160308
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody therapy for Crohn's disease.
Selby W
Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
[No Abstract] [Full Text] [Related]
35. The relationship between infliximab treatment and lymphoma in Crohn's disease.
Bickston SJ; Lichtenstein GR; Arseneau KO; Cohen RB; Cominelli F
Gastroenterology; 1999 Dec; 117(6):1433-7. PubMed ID: 10579985
[TBL] [Abstract][Full Text] [Related]
36. Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
Chauvin A; Le Thuaut A; Belhassan M; Le Baleur Y; Mesli F; Bastuji-Garin S; Delchier JC; Amiot A
Dig Liver Dis; 2014 Aug; 46(8):695-700. PubMed ID: 24893686
[TBL] [Abstract][Full Text] [Related]
37. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
[TBL] [Abstract][Full Text] [Related]
38. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
Sandborn WJ; Hanauer SB
Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177
[TBL] [Abstract][Full Text] [Related]
39. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
Chaparro M; Panes J; García V; Mañosa M; Esteve M; Merino O; Andreu M; Gutierrez A; Gomollón F; Cabriada JL; Montoro MA; Mendoza JL; Nos P; Gisbert JP
J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
[TBL] [Abstract][Full Text] [Related]
40. [Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease].
Chauveau E; Terrier F; Casassus-Buihle D; Moncoucy X; Oddes B
Presse Med; 2005 Apr; 34(8):583-4. PubMed ID: 15962497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
